Independent affiliate guide: en-levelsrx.com is not operated by LevelsRx. We may earn a commission if you enroll through a LevelsRx link. See our disclosure.
LevelsRx Program GuideIndependent GLP-1 telehealth information
Home / Compounded Semaglutide
Medication entity

Compounded Semaglutide Through LevelsRx: Cost, GLP-1 Context & Safety

Semaglutide is a GLP-1 receptor agonist. LevelsRx advertises compounded semaglutide as part of its telehealth weight-management program, but compounded semaglutide is not the same regulatory product as FDA-approved Wegovy.

What is semaglutide?

Semaglutide is an active pharmaceutical ingredient that acts as a glucagon-like peptide-1 receptor agonist. FDA-approved semaglutide products have defined formulations, indications and prescribing information. For weight management, Wegovy is an FDA-approved semaglutide product for eligible patients.

What does LevelsRx advertise?

LevelsRx currently advertises injectable compounded semaglutide starting at $150 per month. It also advertises an oral compounded semaglutide option starting at $150 per month.

Regulatory distinction: compounded semaglutide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed in the same way it reviews approved drugs.

What are the important semaglutide attributes?

Entity
Semaglutide
Drug class
GLP-1 receptor agonist
Approved weight-management product
Wegovy
LevelsRx advertised pathway
Compounded injectable and oral compounded semaglutide
LevelsRx starting price
$150/month for the advertised compounded options
Compounding status
Not FDA-approved

What safety issues should you discuss?

FDA-approved semaglutide labeling includes important warnings and common gastrointestinal side effects. FDA has also separately warned about dosing errors and other problems reported with compounded semaglutide. The appropriate risk discussion depends on the actual product and the patient's medical history.

Ask the prescriber how the dose is measured, how the product is supplied, which pharmacy dispenses it, what to do if a dose is missed, what symptoms require urgent care and how refills or dose changes are handled.

How does semaglutide differ from tirzepatide?

Semaglutide primarily targets the GLP-1 receptor. Tirzepatide targets both GIP and GLP-1 receptors. The two active ingredients should not be treated as simple dose-for-dose substitutes. See our semaglutide vs tirzepatide comparison.

Semaglutide FAQs

Is compounded semaglutide the same as Wegovy?

No. Wegovy is an FDA-approved semaglutide product. Compounded semaglutide is prepared by a compounding pharmacy and is not FDA-approved.

How much does LevelsRx compounded semaglutide start at?

LevelsRx currently advertises compounded semaglutide injection from $150 per month and oral compounded semaglutide from $150 per month.

Is semaglutide a GLP-1 medication?

Yes. Semaglutide is a GLP-1 receptor agonist. Approved semaglutide products have specific indications, formulations and prescribing information.

Check LevelsRx eligibility